MedTrace Logo

Target Volume in Noninvasive Positive Pressure Ventilation

NCT01748656 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2014-03-14

No results posted yet for this study

Summary

Patients with OHS are efficiently managed with long term home-based nocturnal noninvasive positive pressure ventilation (NIPPV). Several NIPPV devices offer the feature of automatically adjusting pressure support (and/or respiratory back-up rate) on the basis of a pre-determined "ideal tidal volume" or "ideal ventilation". However algorithms used to achieve these ideal targets are different among different commercialized devices and the relative efficacy from an algorithm compared to another remains unknown. The main objective is this study is to compare two commercialized NIPPV that have this option

Conditions

  • Obesity Hypoventilation Syndrome

Interventions

DEVICE

IVAPS

IVAPS mode (RESMED Stelar 150) during 1 night

DEVICE

AVAPS

AVAPS mode (PHILIPS-RESPIRONICS-A30) during 1 night

Sponsors & Collaborators

  • ResMed

    collaborator INDUSTRY

  • AGIR à Dom

    lead OTHER

Principal Investigators

  • Jean Louis Pepin, MD PHD · CHU Grenoble France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-09-30
Completion
2014-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01748656 on ClinicalTrials.gov